Aquestive Therapeutics (AQST) Cash from Operations (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Cash from Operations of 14806000.0 for Q1 2026, up 36.73% year-over-year from 10828917.92 in Q1 2025, and down 74.83% quarter-over-quarter from 8469000.0 in Q4 2025.
Aquestive Therapeutics (AQST) Cash from Operations (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Cash from Operations history runs 10 years deep, the most recent figure standing at 14806000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 36.73% year-over-year to 14806000.0; the TTM figure through Mar 2026 stood at 43838000.0 (up 10.12% YoY), while the FY2025 annual figure was 52432000.0, down 46.63% from the prior year.
- Cash from Operations for Q1 2026 stood at 14806000.0, down from 8469000.0 in the prior quarter.
- The five-year high for Cash from Operations was 8816000.0 in Q1 2023, with the low at 23400000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 7907000.0 (2023), against an average of 7011529.41.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations soared 204.4% in 2022, then sank 406.18% in 2024.
- Aquestive Therapeutics' Cash from Operations stood at 8416000.0 in 2022, then plunged by 158.72% to 4942000.0 in 2023, then sank by 31.3% to 6489000.0 in 2024, then plunged by 30.51% to 8469000.0 in 2025, then slumped by 74.83% to 14806000.0 in 2026.
- Business Quant data shows AQST's Cash from Operations at 14806000.0 in Q1 2026, 8469000.0 in Q4 2025, and 12649000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aquestive Therapeutics | 583.72 Mn | 583.72 Mn | 9.80 Mn | -9.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.44 Mn |
| Jun 30, 2026 | -9.44 Mn |
| Mar 31, 2026 | -14.81 Mn |
| Mar 31, 2026 | -14.81 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Sep 30, 2025 | -12.65 Mn |
| Sep 30, 2025 | -12.65 Mn |
| Jun 30, 2025 | -7.91 Mn |
| Jun 30, 2025 | -7.91 Mn |
| Mar 31, 2025 | -23.40 Mn |
| Mar 31, 2025 | -23.40 Mn |
| Dec 31, 2024 | -6.49 Mn |
| Dec 31, 2024 | -6.49 Mn |
| Sep 30, 2024 | -11.88 Mn |
| Sep 30, 2024 | -11.88 Mn |
| Jun 30, 2024 | -7.01 Mn |
| Jun 30, 2024 | -7.01 Mn |
| Mar 31, 2024 | -10.38 Mn |
| Mar 31, 2024 | -10.38 Mn |